文献速递腹部CT

光子计数CT中的胰腺癌:低keV虚拟单能图像提高肿瘤可见性

Pancreatic cancer in photon-counting CT: Low keV virtual monoenergetic images improve tumor conspicuity.
PubMed 文献 · Eur J Radiol · 2024-02-18

回顾性纳入34例胰腺腺癌患者,在光子计数CT上比较40–70 keV虚拟单能与多能重建及动脉期/门静脉期的肿瘤-胰腺实质衰减差和对比噪声比,并由4名放射科医师按5分Likert量表评分。结果显示mono40keV图像肿瘤可见性最佳,但整体图像质量以多能图像最优。

要点

  • 动脉期和门静脉期mono40keV图像的肿瘤-胰腺实质衰减差均显著高于多能图像(p<0.001)。
  • 肿瘤可见性评分在mono40keV最高:动脉期4.3±0.9、门静脉期4.3±1.1。
  • 整体图像质量以多能图像最佳:动脉期4.8±0.5、门静脉期4.7±0.6。

核心结论

  • 基于定量和定性结果,低keV虚拟单能图像显著提高光子计数CT上胰腺腺癌的肿瘤可见性;但读者在整体图像质量上更偏好多能图像。

研究设计与样本

  • 回顾性研究,纳入34例患者,在不同单能级(40至70 keV,5 keV步进)和多能序列上采用感兴趣区测量进行定量图像分析,由4名放射科医师采用5分Likert量表(1=不可识别,5=容易识别)进行定性图像分析。

关键影像表现/征象

  • 肿瘤-胰腺实质衰减差在动脉期和门静脉期不同图像重建间均有显著差异(p<0.001)。
  • 动脉期mono40keV图像肿瘤-胰腺实质衰减差显著高于多能图像(p<0.001)和mono55keV及以上图像(p<0.001)。
  • 门静脉期mono40keV图像肿瘤-胰腺实质衰减差显著高于多能图像(p<0.001)、mono50keV图像(p=0.03)及更高 keV图像(p<0.001)。
  • 对比噪声比呈现相同趋势。
  • 肿瘤可见性在mono40keV图像上评分最佳,动脉期4.3±0.9、门静脉期4.3±1.1;整体图像质量在多能图像上评分最佳,动脉期4.8±0.5、门静脉期4.7±0.6。

诊断标准与关键数值

  • 定性评估采用5分Likert量表:1=不可识别,5=容易识别。
  • 肿瘤与胰腺实质衰减差及对比噪声比用于定量评估,比较不同单能级(40至70 keV,5 keV步进)与多能图像。

临床应用与阅片要点

  • 动脉期和门静脉期mono40keV图像可提高胰腺腺癌的肿瘤可见性,但整体图像质量评分以多能图像更优。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE OF THE STUDY: The aim of the study was to identify differences in the tumor conspicuity of pancreatic adenocarcinomas in different monoenergetic or polyenergetic reconstructions and contrast phases in photon-counting CT (PCCT).

MATERIAL AND METHODS: 34 patients were retrospectively enrolled in this study. Quantitative image analysis was performed with region of interest (ROI) measurements in different monoenergetic levels ranging from 40 up to 70 keV (5-point steps) and polyenergetic series. Tumor-parenchyma attenuation differences and contrast-to-noise-ratio (CNR) were calculated. A qualitative image analysis was accomplished by 4 radiologists using a 5-point Likert scale (1 = "not recognizable" up to 5 = "easy recognizable"). Differences between groups were evaluated for statistical significance using the Friedman test and in case of significant differences pair-wise post-hoc testing with Bonferroni correction was applied.

RESULTS: Tumor-parenchyma attenuation difference was significantly different between the different image reconstructions for both arterial- and portal-venous-phase-images (p < 0.001). Tumor-parenchyma attenuation difference was significantly higher on arterial-phase-images at mono40keV compared to polyenergetic images (p < 0.001) and mono55keV images or higher (p < 0.001). For portal-venous-phase-images tumor-parenchyma attenuation difference was significantly higher on mono40keV images compared to polyenergetic images (p < 0.001) and mono50keV images (p = 0.03) or higher (p < 0.001). The same trend was seen for CNR. Tumor conspicuity was rated best on mono40keV images with 4.3 ± 0.9 for arterial-phase-images and 4.3 ± 1.1 for portal-venous-phase-images. In contrast, overall image quality was rated best on polyenergetic-images with 4.8 ± 0.5 for arterial-phase-images and 4.7 ± 0.6 for portal-venous-phase-images.

CONCLUSION: Low keV virtual monoenergetic images significantly improve the tumor conspicuity of pancreatic adenocarcinomas in PCCT based on quantitative and qualitative results. On the other hand, readers prefer polyenergetic images for overall image quality.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Woeltjen MM, Niehoff JH, Roggel R, et al. Pancreatic cancer in photon-counting CT: Low keV virtual monoenergetic images improve tumor conspicuity. Eur J Radiol. 2024. PMID: 38422607. doi:10.1016/j.ejrad.2024.111374

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。